HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Flumazenil reversal of psychomotor impairment due to midazolam or diazepam for conscious sedation for upper endoscopy.

AbstractBACKGROUND:
Flumazenil is a competitive benzodiazepine antagonist that acts to reverse their sedative and hypnotic effects. It is indicated in the management of benzodiazepine overdose, but its role in the routine reversal of endoscopic conscious sedation has not been defined.
METHODS:
Patients undergoing diagnostic upper endoscopy who received sedation with either diazepam or midazolam alone were given flumazenil 0.2 mg incrementally immediately following the procedure until awake. They were then asked to repeat three psychomotor tests measuring cognitive and motor skills, with their baseline scores compared with postprocedure scores over a 3-hour period.
RESULTS:
Full psychomotor function was restored to baseline values within 30 minutes after flumazenil in 79% of patients, with no differences in the reversal of psychomotor skill impairment observed between diazepam and midazolam sedation. There was no evidence of rebound sedation seen for up to 3 hours. No significant anterograde amnesia was evident in 78% of individuals.
CONCLUSIONS:
These results demonstrate that flumazenil's effects on reversing psychomotor impairment are similar when midazolam or diazepam are used for conscious sedation. However, the potential usefulness of routine flumazenil reversal of conscious sedation will require further evaluation of specific psychomotor performance skills (such as driving a car) before we lift the admonition against leaving the endoscopic suite unattended, driving a vehicle, or operating complicated machinery for several hours.
AuthorsA Kankaria, J H Lewis, G Ginsberg, J Gallagher, F H al-Kawas, C C Nguyen, D E Fleischer, S B Benjamin
JournalGastrointestinal endoscopy (Gastrointest Endosc) Vol. 44 Issue 4 Pg. 416-21 (Oct 1996) ISSN: 0016-5107 [Print] United States
PMID8905360 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Anesthetics, Intravenous
  • Antidotes
  • Flumazenil
  • Diazepam
  • Midazolam
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Akathisia, Drug-Induced (drug therapy, etiology)
  • Anesthetics, Intravenous (adverse effects, therapeutic use)
  • Antidotes (administration & dosage, therapeutic use)
  • Chi-Square Distribution
  • Conscious Sedation (adverse effects)
  • Diazepam (adverse effects, therapeutic use)
  • Duodenoscopy (methods)
  • Esophagoscopy (methods)
  • Female
  • Flumazenil (administration & dosage, therapeutic use)
  • Gastroscopy (methods)
  • Humans
  • Male
  • Midazolam (adverse effects, therapeutic use)
  • Middle Aged
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: